UD TGFβi NK Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UD TGFβi NK Cells, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain [Phase 1, Phase 2]